State of New Jersey Common Pension Fund D maintained its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, Holdings Channel reports. The firm owned 115,000 shares of the medical instruments supplier’s stock at the end of the second quarter. State of New Jersey Common Pension Fund D’s holdings in DENTSPLY SIRONA were worth $7,457,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in XRAY. Teachers Advisors LLC increased its stake in DENTSPLY SIRONA by 18.5% in the fourth quarter. Teachers Advisors LLC now owns 323,176 shares of the medical instruments supplier’s stock worth $18,657,000 after buying an additional 50,432 shares during the last quarter. Chevy Chase Trust Holdings Inc. increased its stake in DENTSPLY SIRONA by 1.5% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 202,398 shares of the medical instruments supplier’s stock worth $12,638,000 after buying an additional 2,992 shares during the last quarter. Raymond James Trust N.A. increased its stake in DENTSPLY SIRONA by 11.7% in the first quarter. Raymond James Trust N.A. now owns 6,031 shares of the medical instruments supplier’s stock worth $377,000 after buying an additional 630 shares during the last quarter. Creative Planning increased its stake in DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock worth $425,000 after buying an additional 70 shares during the last quarter. Finally, Gulf International Bank UK Ltd increased its stake in DENTSPLY SIRONA by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 74,565 shares of the medical instruments supplier’s stock worth $4,655,000 after buying an additional 1,000 shares during the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at 55.33 on Friday. The stock’s 50 day moving average is $62.91 and its 200-day moving average is $62.30. The firm’s market cap is $12.69 billion. DENTSPLY SIRONA Inc. has a 12-month low of $54.49 and a 12-month high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.65. The company had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.76 EPS. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post $2.73 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.09%.

COPYRIGHT VIOLATION NOTICE: “State of New Jersey Common Pension Fund D Holds Position in DENTSPLY SIRONA Inc. (XRAY)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/state-of-new-jersey-common-pension-fund-d-holds-position-in-dentsply-sirona-inc-xray/1476805.html.

A number of analysts recently commented on XRAY shares. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday, April 19th. Goldman Sachs Group, Inc. (The) downgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and dropped their target price for the stock from $60.00 to $55.00 in a report on Tuesday, May 23rd. Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, June 10th. Finally, HC Wainwright started coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. DENTSPLY SIRONA presently has a consensus rating of “Buy” and an average target price of $66.75.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.